Table 2. Factors associated with BD/TDDratio, insulin doses per day and insulin doses per kilogram of body weight (revised by gender) in all patients, insulin alone treated patients and insulin combination with metformin treated patients.*.
| Variable | all patients | insulin alone treated patients | insulin combination with metformin treated patients | ||||||
| BD/TDD ratio | insulin dosesper day | insulin dosesper kilogram | BD/TDD ratio | insulin dosesper day | insulin dosesper kilogram | BD/TDD ratio | insulin dosesper day | insulin dosesper kilogram | |
| age | −0.164 | −0.179 | −0.145 | / | −0.225 | −0.183 | −0.183 | −0.173 | −0.127 |
| DM duration | 0.102 | 0.276 | 0.259 | / | 0.266 | 0.244 | 0.143 | 0.271 | 0.244 |
| BMI | 0.152 | 0.282 | −0.117 | 0.177 | 0.306 | / | 0.151 | 0.218 | −0.137 |
| HbA1c | 0.129 | 0.21 | 0.23 | / | 0.207 | 0.243 | 0.132 | 0.213 | 0.208 |
| Fasting C peptide | / | / | / | / | / | / | / | / | / |
| Postprandial C peptide | −0.111 | / | / | −0.204 | / | / | −0.082 | / | / |
| FBG (Admission) | 0.12 | 0.067 | 0.079 | / | / | / | 0.153 | / | / |
| 2 hrPBG (Admission) | / | 0.076 | 0.067 | / | / | / | / | 0.112 | 0.107 |
| FBG (Discharged from hospital) | 0.127 | 0.151 | 0.126 | / | / | / | 0.18 | 0.204 | 0.157 |
| 2 hrPBG (Discharged from hospital) | −0.117 | / | / | −0.124 | 0.096 | 0.119 | −0.124 | / | / |
| CRE(umol/L) | −0.131 | / | / | / | / | / | −0.113 | / | / |
| Metformin | 0.092 | / | / | / | / | / | / | / | / |
*
The value was described as β values in multiple linear regression analysis (p<0.01).